QSAM Biosciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Subsequent Events (Details Narrative) - USD ($)	Aug. 01, 2018	Jul. 27, 2018	Jul. 13, 2018	Jul. 31, 2018	Jun. 30, 2018
Follow-On Bridge Offering [Member] \| One Institutional Investors [Member]
Face amount of debt					$ 250,000
Subsequent Event [Member] \| Stock Purchase Agreement [Member] \| George B. Wittmer Associates Inc. [Member]
Purchase price of stock during period		$ 4,500,000
Subsequent Event [Member] \| Employee, Director and Consultant [Member]
Stock options description			Board approved the repricing of current employee, director and consultant stock options to $0.10
Defined permanant funding amount			$ 4,000,000
Subsequent Event [Member] \| CEO [Member]
Base salary			275,000
Subsequent Event [Member] \| President [Member]
Base salary			$ 220,000
Subsequent Event [Member] \| Mr. Shields [Member]
Base salary	$ 220,000
Renewal option, term	2 years
Subsequent Event [Member] \| Follow-On Bridge Offering [Member] \| One Institutional Investors [Member]
Face amount of debt				$ 250,000
Subsequent Event [Member] \| Two Year Promissory Notes [Member] \| Stock Purchase Agreement [Member] \| George B. Wittmer Associates Inc. [Member]
Purchase price of stock during period		$ 500,000